These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21412423)

  • 1. Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease.
    Adlard PA; Bica L; White AR; Nurjono M; Filiz G; Crouch PJ; Donnelly PS; Cappai R; Finkelstein DI; Bush AI
    PLoS One; 2011 Mar; 6(3):e17669. PubMed ID: 21412423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to rapidly prevent age-related cognitive decline.
    Adlard PA; Sedjahtera A; Gunawan L; Bray L; Hare D; Lear J; Doble P; Bush AI; Finkelstein DI; Cherny RA
    Aging Cell; 2014 Apr; 13(2):351-9. PubMed ID: 24305557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease.
    Wang R; Palavicini JP; Wang H; Maiti P; Bianchi E; Xu S; Lloyd BN; Dawson-Scully K; Kang DE; Lakshmana MK
    Neurobiol Dis; 2014 Sep; 69():169-79. PubMed ID: 24892886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-3-n-Butylphthalide improves synaptic and dendritic spine plasticity and ameliorates neurite pathology in Alzheimer's disease mouse model and cultured hippocampal neurons.
    Huang L; Lan J; Tang J; Kang Y; Feng X; Wu L; Peng Y
    Mol Neurobiol; 2021 Mar; 58(3):1260-1274. PubMed ID: 33146400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthoceraside modulates NR2B-containing NMDA receptors at synapses and rescues learning-memory deficits in APP/PS1 transgenic mice.
    Zhu L; Yang L; Zhao X; Liu D; Guo X; Liu P; Chi T; Ji X; Zou L
    Psychopharmacology (Berl); 2018 Jan; 235(1):337-349. PubMed ID: 29124300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.
    Lannfelt L; Blennow K; Zetterberg H; Batsman S; Ames D; Harrison J; Masters CL; Targum S; Bush AI; Murdoch R; Wilson J; Ritchie CW;
    Lancet Neurol; 2008 Sep; 7(9):779-86. PubMed ID: 18672400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoxetine delays the cognitive function decline and synaptic changes in a transgenic mouse model of early Alzheimer's disease.
    Zhou CN; Chao FL; Zhang Y; Jiang L; Zhang L; Fan JH; Wu YX; Dou XY; Tang Y
    J Comp Neurol; 2019 Jun; 527(8):1378-1387. PubMed ID: 30592045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses.
    Faux NG; Ritchie CW; Gunn A; Rembach A; Tsatsanis A; Bedo J; Harrison J; Lannfelt L; Blennow K; Zetterberg H; Ingelsson M; Masters CL; Tanzi RE; Cummings JL; Herd CM; Bush AI
    J Alzheimers Dis; 2010; 20(2):509-16. PubMed ID: 20164561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthoceras sorbifolia extracts ameliorate dendritic spine deficiency and cognitive decline via upregulation of BDNF expression in a rat model of Alzheimer's disease.
    Li Y; Xu J; Xu P; Song S; Liu P; Chi T; Ji X; Jin G; Qiu S; Hou Y; Zheng C; Wang L; Meng D; Zou L
    Neurosci Lett; 2016 Aug; 629():208-214. PubMed ID: 27412235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
    Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
    CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Bactericidal Mechanisms of the Zinc Ionophore PBT2.
    Harbison-Price N; Ferguson SA; Heikal A; Taiaroa G; Hards K; Nakatani Y; Rennison D; Brimble MA; El-Deeb IM; Bohlmann L; McDevitt CA; von Itzstein M; Walker MJ; Cook GM
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32188750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model.
    Long ZM; Zhao L; Jiang R; Wang KJ; Luo SF; Zheng M; Li XF; He GQ
    CNS Neurosci Ther; 2015 Nov; 21(11):887-97. PubMed ID: 26385876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta: a putative intra-spinal microtubule-depolymerizer to induce synapse-loss or dentritic spine shortening in Alzheimer's disease.
    Mitsuyama F; Futatsugi Y; Okuya M; Karagiozov K; Peev N; Kato Y; Kanno T; Sano H; Koide T
    Ital J Anat Embryol; 2009; 114(2-3):109-20. PubMed ID: 20198823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D.
    Penazzi L; Tackenberg C; Ghori A; Golovyashkina N; Niewidok B; Selle K; Ballatore C; Smith AB; Bakota L; Brandt R
    Neuropharmacology; 2016 Jun; 105():84-95. PubMed ID: 26772969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease.
    Richetin K; Moulis M; Millet A; Arràzola MS; Andraini T; Hua J; Davezac N; Roybon L; Belenguer P; Miquel MC; Rampon C
    Neurobiol Dis; 2017 Jun; 102():113-124. PubMed ID: 28286181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease.
    Sun B; Halabisky B; Zhou Y; Palop JJ; Yu G; Mucke L; Gan L
    Cell Stem Cell; 2009 Dec; 5(6):624-33. PubMed ID: 19951690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model.
    Lee ST; Chu K; Jung KH; Kim JH; Huh JY; Yoon H; Park DK; Lim JY; Kim JM; Jeon D; Ryu H; Lee SK; Kim M; Roh JK
    Ann Neurol; 2012 Aug; 72(2):269-77. PubMed ID: 22926857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.